Democratizing access to comprehensive genomic profiling (CGP) with distributed kits
Providing revolutionary comprehensive genomic profiling solutions and services
All patients deserve to have access to best-in-class genomic testing. PGDx is dedicated to empowering personalized care by providing rapid precision oncology diagnostics to all patients.
We remove barriers to precision oncology testing in order to make timely, personalized cancer treatments a reality for all. Discover our proven pan solid tumor tissue and liquid biopsy precision oncology solutions, backed by turn-key bioinformatics that enable rapid, in-house testing. Explore our services and partnership opportunities designed to advance cancer research and CDx development.
Our goal is to make rapid, reliable CGP insights available in laboratories worldwide to empower local care teams with data you control and meaningful results that guide personalized cancer care. Our portfolio is backed by advanced proprietary bioinformatics, a fully automated solution that delivers the answers you need, every time.
The PGDx elio tissue complete test enables rapid and actionable genomic insights for all patients with advanced cancer with a comprehensive tumor profiling kit.
The PGDx elio plasma complete assay is a liquid biopsy CGP kit that analyzes circulating tumor DNA for pan solid tumor biomarker discovery, eliminating the need for an invasive tissue biopsy.
The PGDx elio plasma resolve assay is a focused liquid biopsy kit for pan solid tumor genomic analysis.